WeVote
Log In

Bill

Bill

HB 1853

Relating to the availability of certain information regarding persons who provide materials used in the execution of a convict.

89th Legislature (2025) Introduced by Joe Moody

Texas bill requiring disclosure of execution material suppliers' identities to increase transparency in capital punishment administration processes.

Referred to Corrections
#crimes--capitalpunishment(i0195) #openrecords(i0548)
0
WeVote Research Nonpartisan
Bill Summary · HB 1853

Legislative bill overview

HB 1853 would require the state to disclose the identities and other information about suppliers and manufacturers of materials used in executions. Currently, Texas law allows these suppliers to remain anonymous. The bill seeks to increase transparency around the execution process by making publicly available details about companies and individuals involved in providing lethal injection drugs and equipment.

Why is this important

Execution supply chains operate largely in secrecy, with pharmaceutical companies and medical suppliers actively avoiding identification to prevent legal liability, boycotts, and reputational damage. This bill directly addresses whether citizens and oversight bodies have a right to know who profits from or facilitates state executions, raising fundamental questions about government transparency, accountability, and the ethics of capital punishment administration.

Potential points of contention

  • Drug availability concerns: Pharmaceutical manufacturers have actively withdrawn from execution supply chains; mandated disclosure could further limit availability of execution materials, potentially delaying or complicating executions
  • Supplier protection vs. transparency: Companies argue anonymity protects them from litigation and harassment; disclosure requirements may face legal challenges on First Amendment and due process grounds
  • Death penalty philosophy: The bill implicitly supports capital punishment oversight through transparency, while death penalty opponents may view it as legitimizing executions rather than abolishing them
  • Liability exposure: Identified suppliers could face civil lawsuits from inmates' families or criminal defense arguments about drug quality and administration

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.